Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7311785
Reference Type
Journal Article
Title
Malignant transformation of oral proliferative verrucous leukoplakia: a series of 48 patients with suggestions for management
Author(s)
Favia, G; Capodiferro, S; Limongelli, L; Tempesta, A; Maiorano, E
Year
2021
Is Peer Reviewed?
Yes
Journal
International Journal of Oral and Maxillofacial Surgery
ISSN:
0901-5027
EISSN:
1399-0020
Volume
50
Issue
1
Page Numbers
14-20
Language
English
PMID
32586723
DOI
10.1016/j.ijom.2020.05.019
Web of Science Id
WOS:000702937800003
Abstract
Proliferative verrucous leukoplakia (PVL) is a rare and refractory form of oral mucosal leukoplakia of unknown origin, characterized by high rates of malignant transformation. Different diagnostic criteria, terminologies, and therapeutic approaches have been proposed since the first report in 1985. There remains no general agreement regarding the clinical and histological diagnosis, prevention, and correct management of this disease. This retrospective study investigated 48 patients affected by PVL showing at least one malignant transformation and followed up at 2-month intervals. Twenty-five were female (52.1%) and 23 (47.9%) were male; their median age was 67 years (range 40-93 years). Follow-up ranged from 18 to 240 months. Clinical examination included the use of Lugol's solution to prevent clinical underestimation of the margins and toluidine blue for suspicious areas. Surgical excision by scalpel was the preferred treatment for suspicious lesions, with only five carcinomas surgically removed by diode laser and two by CO2 laser. All specimens were accurately mapped after formalin fixation. Fifteen patients (31.3%; 10 female, five male) developed one oral carcinoma, while 33 (68.7%) developed two or more primary tumours (range 3-12). Only four patients (8.3%), who developed between 2 and 8 oral squamous cell carcinomas (OSCCs), died of tumour-related causes. The pre-surgical clinical workup, subsequent surgical treatment, and follow-up are key to success for patients affected by PVL with malignant transformation into stage 1 OSCC and/or verrucous carcinoma, leading to a high overall survival rate.
Keywords
potentially malignant disorders; proliferative verrucous leukoplakia; malignant transformation; oral squamous cell carcinoma; oral cavity
Tags
IRIS
•
Formaldehyde [archived]
HAWC
Human cancer
Excluded
Search Update 2018-2021
Human cancer studies
PubMed
•
IRIS Formaldehyde (Inhalation) [Final 2024]
Literature Indexing
PubMed
2021 Systematic Evidence Map
Literature Identification
Cancer in Humans
Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity